Augmented debridement for implant related chronic osteomyelitis with an absorbable, gentamycin loaded calcium sulfate/hydroxyapatite biocomposite
-
Add time:09/24/2019 Source:sciencedirect.com
We report outcomes from 52 patients with chronic osteomyelitis from implant infection treated with a single stage protocol including debridement augmented with application of CERAMENT™/G biocomposite after resection of Cierny-Mader (C-M) stage III and IV chronic osteomyelitis. Mean age was 53 years with a mean follow up of 17 months. Infection was eradicated in 48 (92.3%) patients. There were four (7.7%) recurrences. Eighteen patients (35%) had a flap. Staphylococci (51%) and Enterococci (15%) were the commonest microorganisms. Local antibiotic augmentation (CERAMENT™/G biocomposite) with dead space management is effective in the treatment of implant related chronic osteomyelitis.
We also recommend Trading Suppliers and Manufacturers of Gentamycin sulfate (cas 1405-41-0). Pls Click Website Link as below: cas 1405-41-0 suppliers
Prev:Curvature-Dependent Recognition of Ethanolamine Phospholipids by Duramycin and cinnamycin (cas 1405-39-6)☆
Next:Development of a novel bead-based 96-well filtration plate competitive immunoassay for the detection of Gentamycin) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Gentamycin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. II. The case of Gentamycin sulfate (cas 1405-41-0) in high molecular weight poly(dl-lactic acid) and poly(l-lactic acid)09/30/2019
- Document headingModulatory effects of dietary inclusion of garlic (Allium sativum) on gentamycin–induced hepatotoxicity and oxidative stress in rats09/29/2019
- Development of an enzyme-linked immunosorbent assay for the detection of gentamycin residues in animal-derived foods09/28/2019
- Gentamycin/poly (lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. III. The case of Gentamycin sulfate (cas 1405-41-0) in films prepared from high and low molecular weight poly (DL-lactic acids)10/01/2019
- Renoprotective effects of stevia (Stevia rebaudiana Bertoni), amlodipine, valsartan, and losartan in gentamycin-induced nephrotoxicity in the rat model: Biochemical, hematological and histological approaches09/27/2019
- Gentamycin/poly(lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. I. The case of gentamycin base and Gentamycin sulfate (cas 1405-41-0) in poly(dl-lactic acid) oligomers09/26/2019
- Development of a novel bead-based 96-well filtration plate competitive immunoassay for the detection of Gentamycin09/25/2019
